Abstract:Background. Plague is an especially dangerous natural focal infectious disease belonging to a group of quarantine infections. There are eleven natural plague foci in Russian Federation. In Republic Tyva plague endemic territories include Ovyur, Mongun-Taigin and Tes-Hem areas where Y. pestis strains are intermittently isolated from Citellus undulates. Population living at the territory of the natural foci get immunoprophylaxis against plague at complication of epizootic and epidemic conditions.This paper prese… Show more
“…A detected increase in IgE contents in blood of some volunteers was still within reference values for conditionally healthy donors and didn't correlate with increased IL-4 contents. Increased IgE contents in people who were going to get vaccinated or just after vaccination were also revealed in similar research performed in the Mountain Altai natural plague focus and they were also within reference ranges fixed for conditionally healthy donors [12].…”
supporting
confidence: 72%
“…At the same time, SI for IL-4 grew in all groups but this growth persisted up to the 12 th months in Group 3 only. It should be noted that similar trends in IFN-γ, TNF-α and IL-4 responses were registered in volunteers who got vaccinated for the 1 st time in the Mountain Altai and Tuva Mountain natural plague foci [12,15].…”
To provide better opportunities for managing both risks caused by vaccination and risks of epidemiological complications, immunologic monitoring over people vaccinated with live dried plague vaccine (LPV) due to epidemiologic indications was performed. Our research goal was to assess whether immunologic monitoring over people vaccinated against plague yielded informative results; it was done to substantiate activities aimed at improving procedures for LPV application. Immunologic monitoring was performed from 2016 to 2019 in the Caspian sand natural plague focus according to conventional procedures for assessing humoral and cellular components in immunity. We determined immunologic parameters in 217 volunteers vaccinated with LPV and 130 healthy donors (the reference group) prior to and 1 and 12 months after vaccination. We suggested a methodical approach based on aggregated analysis of the summated immune response predictors chosen for estimation in volunteers vaccinated with LPV and giving score values to them; it allows revealing people who react to plague microbe antigens predominantly as per cellular, humoral, or mixed type. Immunologic monitoring results proved that it was safe to apply LPV; they allowed characterizing trends occurring in immunological restructuring in vaccinated volunteers, determining limits of fluctuation in individual parameters of an immune response to the vaccine, and revealing people with both normal and changed (reduced or increased) immunologic reactivity to LPV. If monitoring data are taken into account, it provides an opportunity to predict vaccination results as per epidemiological parameters, to reveal groups with normal, high, or low immune reactivity to plague microbe antigens in order to determine people in them who need an individual approach when it comes down to anti-plague vaccination.
“…A detected increase in IgE contents in blood of some volunteers was still within reference values for conditionally healthy donors and didn't correlate with increased IL-4 contents. Increased IgE contents in people who were going to get vaccinated or just after vaccination were also revealed in similar research performed in the Mountain Altai natural plague focus and they were also within reference ranges fixed for conditionally healthy donors [12].…”
supporting
confidence: 72%
“…At the same time, SI for IL-4 grew in all groups but this growth persisted up to the 12 th months in Group 3 only. It should be noted that similar trends in IFN-γ, TNF-α and IL-4 responses were registered in volunteers who got vaccinated for the 1 st time in the Mountain Altai and Tuva Mountain natural plague foci [12,15].…”
To provide better opportunities for managing both risks caused by vaccination and risks of epidemiological complications, immunologic monitoring over people vaccinated with live dried plague vaccine (LPV) due to epidemiologic indications was performed. Our research goal was to assess whether immunologic monitoring over people vaccinated against plague yielded informative results; it was done to substantiate activities aimed at improving procedures for LPV application. Immunologic monitoring was performed from 2016 to 2019 in the Caspian sand natural plague focus according to conventional procedures for assessing humoral and cellular components in immunity. We determined immunologic parameters in 217 volunteers vaccinated with LPV and 130 healthy donors (the reference group) prior to and 1 and 12 months after vaccination. We suggested a methodical approach based on aggregated analysis of the summated immune response predictors chosen for estimation in volunteers vaccinated with LPV and giving score values to them; it allows revealing people who react to plague microbe antigens predominantly as per cellular, humoral, or mixed type. Immunologic monitoring results proved that it was safe to apply LPV; they allowed characterizing trends occurring in immunological restructuring in vaccinated volunteers, determining limits of fluctuation in individual parameters of an immune response to the vaccine, and revealing people with both normal and changed (reduced or increased) immunologic reactivity to LPV. If monitoring data are taken into account, it provides an opportunity to predict vaccination results as per epidemiological parameters, to reveal groups with normal, high, or low immune reactivity to plague microbe antigens in order to determine people in them who need an individual approach when it comes down to anti-plague vaccination.
“…Анализ данных многолетнего иммунологиче ского мониторинга уровня специфических антител к F1 Y. pestis у привитых против чумы континген тов показал, что фаза стабилизации выработки антител, или стационарный период, в течение ко торого титр специфических антител к F1 Y. pestis остаётся стабильно высоким, составляет 3-6 ме сяцев после вакцинации. В предыдущих работах установлено, что антительный ответ на ВЧЖ ха рактеризуется вариабельностью и регистрируется в широком диапазоне -от 4 до 85% привитых в зависимости от кратности предыдущих вакцина ций [5,6].…”
Relevance. As part of ensuring sanitary and epidemiological well-being, in the territory of natural plague foci of the Russian Federation, according to epidemiological indications, the population is vaccinated against this infection. The lack of a unified scheme for evaluating the effectiveness of vaccination dictates the need to develop universal express methods that allow screening studies of anti-plague immunity, including in the field.Aims. To evaluate the effectiveness of the express method for the direct detection of antibodies to Yersinia pestis in biological material using microstructural glass waveguides with a hollow core (MGW HC) as immunosensors in studying the dynamics of seroconversion in people vaccinated with the plague live people.Materials and methods. In the study, blood serum samples were taken from 30 individuals vaccinated according to epidemic indications with the live plague vaccine (PLV) and 30 volunteers who were not vaccinated and did not have a history of contact with the plague agent.Results. An assessment was made of the possibility of using the method of direct detection of antibodies using MGW HC at different time intervals according to the receipt of blood sera in the framework of monitoring vaccinated individuals from among the inhabitants of the Caspian sandy natural plague focus. The presence of specific antibodies to the F1 protein in the blood serum of vaccinated volunteers was revealed both with the help of ELISA and with the use of MGW HC. The speed of the method of direct detection of antibodies (maximum 2 minutes per test), the absence of the need to use speciesspecific secondary antibodies, enzymes and substrates and additional costs for laborious sample preparation were noted.Conclusions. The method of direct detection of antibodies using glass microstructural waveguides is promising for introduction into the list of express methods for assessing the immunological effectiveness of antiplague vaccination.
“…Выявленное некоторое увеличение уровня IgЕ в крови отдельных добровольцев не выходило за пределы референсных значений для условно здоровых Т а б л и ц а 1 [12]. В пользу безопасности применения ВЧЖ свидетельствовали и данные об отсутствии после вакцинации увеличения доли лиц со снижением ИРИ через 12 месяцев после очередной вакцинации по отношению к исходному уровню этого показателя у добровольцев до начала вакцинальной кампании.…”
unclassified
“…В то же время ИС для IL-4 во всех группах несколько повышался, но только в группе 3 повышение сохранялось до 12-го месяца. Стоит отметить, что аналогичная тенденция в реакции IFN-γ, TNF-α и IL-4 была зарегистрирована у впервые вакцинированных добровольцев из Горно-Алтайского высокогорного и Тувинского горного природных очагов чумы [12,15].…”
To provide better opportunities for managing both risks caused by vaccination and risks of epidemiological complications, immunologic monitoring over people vaccinated with live dried plague vaccine (LPV) due to epidemiologic indications was performed. Our research goal was to assess whether immunologic monitoring over people vaccinated against plague yielded informative results; it was done to substantiate activities aimed at improving procedures for LPV application. Immunologic monitoring was performed from 2016 to 2019 in the Caspian sand natural plague focus according to conventional procedures for assessing humoral and cellular components in immunity. We determined immunologic parameters in 217 volunteers vaccinated with LPV and 130 healthy donors (the reference group) prior to and 1 and 12 months after vaccination. We suggested a methodical approach based on aggregated analysis of the summated immune response predictors chosen for estimation in volunteers vaccinated with LPV and giving score values to them; it allows revealing people who react to plague microbe antigens predominantly as per cellular, humoral, or mixed type. Immunologic monitoring results proved that it was safe to apply LPV; they allowed characterizing trends occurring in immunological restructuring in vaccinated volunteers, determining limits of fluctuation in individual parameters of an immune response to the vaccine, and revealing people with both normal and changed (reduced or increased) immunologic reactivity to LPV. If monitoring data are taken into account, it provides an opportunity to predict vaccination results as per epidemiological parameters, to reveal groups with normal, high, or low immune reactivity to plague microbe antigens in order to determine people in them who need an individual approach when it comes down to anti-plague vaccination.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.